Finally, the Company is targeting completion of its
expanded manufacturing facility by the end of FY22.
Operating capacity from the expansion will come on-line
in phases as necessary, based on demand requirements
for AROA’s products. AROA anticipates that
following completion, it will have sufficient aggregate
manufacturing facilities to support approximately
NZ$100 million in sales per annum
- Forums
- ASX - By Stock
- ARX
- Annual Report CEO's Report
ARX
aroa biosurgery limited
Add to My Watchlist
3.60%
!
67.0¢

Annual Report CEO's Report
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
67.0¢ |
Change
-0.025(3.60%) |
Mkt cap ! $231.1M |
Open | High | Low | Value | Volume |
69.5¢ | 69.5¢ | 66.5¢ | $126.1K | 187.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 65.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
68.0¢ | 7447 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 0.655 |
6 | 44631 | 0.650 |
1 | 15000 | 0.640 |
2 | 7788 | 0.630 |
1 | 1598 | 0.625 |
Price($) | Vol. | No. |
---|---|---|
0.680 | 7447 | 1 |
0.685 | 4258 | 1 |
0.690 | 10000 | 1 |
0.695 | 725 | 1 |
0.700 | 53792 | 6 |
Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
Featured News
ARX (ASX) Chart |